Instil Bio, Inc.TILEarnings & Financial Report
Nasdaq
TIL Q3 2025 Key Financial Metrics
Revenue
$2.2M
Gross Profit
N/A
Operating Profit
$-15.0M
Net Profit
$-13.6M
Gross Margin
N/A
Operating Margin
-670.0%
Net Margin
-606.0%
YoY Growth
50.2%
EPS
$-2.01
Financial Flow
Instil Bio, Inc. Q3 2025 Financial Summary
Instil Bio, Inc. reported revenue of $2.2M for Q3 2025, with a net profit of $-13.6M (-606.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $2.2M |
|---|---|
| Net Profit | $-13.6M |
| Gross Margin | N/A |
| Operating Margin | -670.0% |
| Report Period | Q3 2025 |
Instil Bio, Inc. Annual Revenue by Year
Instil Bio, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $4.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $4.3M |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1.5M | $2.8M | $2.2M | $2.2M | $2.2M |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 50.2% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $340.3M | $306.3M | $294.3M | $272.6M | $263.6M | $237.4M | $231.0M | $211.8M |
| Liabilities | $106.2M | $100.5M | $99.3M | $96.2M | $94.1M | $92.5M | $99.3M | $91.3M |
| Equity | $234.0M | $205.8M | $195.0M | $176.3M | $169.4M | $144.9M | $131.7M | $120.4M |
Cash Flow
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-14.4M | $-14.4M | $-10.6M | $-20.1M | $-10.6M | $-4.2M | $-14.8M | $-10.6M |